volume 55, issue 3, P281-309 2015
DOI: 10.1016/j.rbr.2014.06.006
View full text
|
|
Share

Abstract: The treatment of autoimmune rheumatic diseases has gradually improved over the last half century, which has been expanded with the contribution of biological therapies or immunobiopharmaceuticals. However, we must be alert to the possibilities of undesirable effects from the use of this class of medications. The Brazilian Society of Rheumatology (Sociedade Brasileira de Reumatologia/SBR) produced a document based on a comprehensive literature review on the safety aspects of this class of drugs, specifically wi…

Expand abstract

Search citation statements

Order By: Relevance

Paper Sections

0
0
0
0
0

Citation Types

0
7
0
2

Publication Types

Select...

Relationship

0
0

Authors

Journals